Evidence map›Paper›PMID 38645962›Full record

ArticleRadiology case reports2024

Atypical brain MRI findings in a patient with treatment responsive anti-IgLON5 disease.

Moein Zandiehvakili, Cathy Kexin Cui, Bronte Jeffrey, Florence Ching-Fen Chang, Jonathan Emerson, Samuel Conyngham

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Radiology case reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Pooled it
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Moein ZandiehvakiliDepartment of Radiology, Westmead hospital, Sydney, Australia.
Cathy Kexin CuiDepartment of Neurology, Westmead hospital, Sydney, Australia.
Bronte JeffreyDepartment of Immunology, Westmead hospital, Sydney, Australia.
Florence Ching-Fen ChangDepartment of Neurology, Westmead hospital, Sydney, Australia.
Jonathan EmersonDepartment of Immunology, Westmead hospital, Sydney, Australia.
Samuel ConynghamDepartment of Radiology, Westmead hospital, Sydney, Australia.
Westmead Hospital · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Anti-IgLON5 disease is a rare autoimmune neurological condition which was relatively recently described in the literature. This syndrome encompasses a range of clinical manifestations with most cases showing unremarkable findings on brain magnetic resonance imaging (MRI). Here, we report a case of a 61-year-old female patient with unique brain MRI features that, to the best of our knowledge, has not been reported in the literature before. Following treatment including immunotherapy, the patient experienced significant improvement clinically accompanied by radiological improvement on the follow-up imaging.

Indexed as

Anti-IgLON5 diseaseAutoimmune encephalitisBrain MRIImmunotherapy

Identifiers

PMID38645962
PMCPMC11026686
OpenAlexW4394784175

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.